AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
申请人:Bahmanyar Sogole
公开号:US20100093698A1
公开(公告)日:2010-04-15
Provided herein are Heteroaryl Compounds of formula (I):
wherein R
1
and R
2
are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing inflammatory conditions or cancer, and conditions treatable or preventable by inhibition of a kinase or a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a subject in need thereof.
PAVIA M. R.; TAYLOR CH. P.; HERSHENSON F. M.; LOBBESTAEL S. J., J. MED. CHEM., 30,(1987) N 7, 1210-1214
作者:PAVIA M. R.、 TAYLOR CH. P.、 HERSHENSON F. M.、 LOBBESTAEL S. J.
DOI:——
日期:——
AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS
申请人:Signal Pharmaceuticals, LLC
公开号:EP2344494A1
公开(公告)日:2011-07-20
US8299056B2
申请人:——
公开号:US8299056B2
公开(公告)日:2012-10-30
[EN] AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS<br/>[FR] AMINOTRIAZOLOPYRIDINES ET LEUR UTILISATION COMME INHIBITEURS DE KINASE
申请人:SIGNAL PHARM LLC
公开号:WO2010027500A1
公开(公告)日:2010-03-11
Provided herein are Heteroaryl Compounds of formula (I): wherein R1 and R2 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing inflammatory conditions or cancer, and conditions treatable or preventable by inhibition of a kinase or a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a subject in need thereof.